RAGE-mediated inflammation in patients with septic shock

Journal of Surgical Research

Volumn 202, Issue 2, 2016, Pages 315-327

  Hofer, Stefan ^a   Uhle, Florian ^a   Fleming, Thomas ^a   Hell, Christian ^a   Schmoch, Thomas ^a   Bruckner, Thomas ^b   Weigand, Markus A ^a   Brenner, Thorsten ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Carboxymethyllysine; Human serum albumin; Myeloid related protein 8 14; Receptor for advanced glycation endproducts; Retinol binding protein; S100A8 A9

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; CALGRANULIN A; CALGRANULIN B; HUMAN SERUM ALBUMIN; RETINOL BINDING PROTEIN; BIOLOGICAL MARKER; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MOK PROTEIN, HUMAN; TUMOR ANTIGEN;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; INFLAMMATION; LEUKOCYTE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; BLOOD; CASE CONTROL STUDY; NORMAL HUMAN; PILOT STUDY;

ANTIGENS, NEOPLASM; BIOMARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEALTHY VOLUNTEERS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PILOT PROJECTS; PROTEIN ISOFORMS; SHOCK, SEPTIC;

EID: 84964063164     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2016.01.019     Document Type: Article

References (57)

1. D.C. Angus, W.T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M.R. Pinsky Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 2001 1303
2. D. Annane, P. Aegerter, M.C. Jars-Guincestre, and B. Guidet Current epidemiology of septic shock: the CUB-Rea Network Am J Respir Crit Care Med 168 2003 165
3. M.A. Weigand, C. Horner, H.J. Bardenheuer, and A. Bouchon The systemic inflammatory response syndrome Best Pract Res Clin Anaesthesiol 18 2004 455
4. C. Bopp, A. Bierhaus, S. Hofer, and et al. Bench-to-bedside review: the inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis Crit Care 12 2008 201
5. X. Zhang, and D.M. Mosser Macrophage activation by endogenous danger signals J Pathol 214 2008 161
6. A. Bierhaus, P.M. Humpert, M. Morcos, and et al. Understanding RAGE, the receptor for advanced glycation end products J Mol Med (Berl) 83 2005 876
7. A. Bierhaus, and P.P. Nawroth Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications Diabetologia 52 2009 2251
8. A. Bierhaus, S. Schiekofer, M. Schwaninger, and et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB Diabetes 50 2001 2792
9. B. Liliensiek, M.A. Weigand, A. Bierhaus, and et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response J Clin Invest 113 2004 1641
10. H.J. Huttunen, C. Fages, and H. Rauvala Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways J Biol Chem 274 1999 19919
11. S. Du Yan, H. Zhu, J. Fu, and et al. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease Proc Natl Acad Sci U S A 94 1997 5296
12. O. Hori, J. Brett, T. Slattery, and et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system J Biol Chem 270 1995 25752
13. M. Neeper, A.M. Schmidt, J. Brett, and et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins J Biol Chem 267 1992 14998
14. A.M. Schmidt, M. Vianna, M. Gerlach, and et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface J Biol Chem 267 1992 14987
15. S.J. Cho, G. Roman, F. Yeboah, and Y. Konishi The road to advanced glycation end products: a mechanistic perspective Curr Med Chem 14 2007 1653
16. Z. Turk Glycotoxines, carbonyl stress and relevance to diabetes and its complications Physiol Res 59 2010 147
17. T. Brenner, T. Fleming, F. Uhle, and et al. Methylglyoxal as a new biomarker in patients with septic shock: an observational clinical study Crit Care 18 2014 683
18. M.M. Levy, M.P. Fink, J.C. Marshall, and et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis Definitions Conference Crit Care Med 31 2003 1250
19. J. Brett, A.M. Schmidt, S.D. Yan, and et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues Am J Pathol 143 1993 1699
20. A.M. Schmidt, S.D. Yan, J. Brett, R. Mora, R. Nowygrod, and D. Stern Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products J Clin Invest 91 1993 2155
21. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J Clin Invest 108 2001 949
22. E.C. Lutterloh, S.M. Opal, D.D. Pittman, and et al. Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection Crit Care 11 2007 R122
23. C. Bopp, S. Hofer, J. Weitz, and et al. sRAGE is elevated in septic patients and associated with patients outcome J Surg Res 147 2008 79
24. L.E. Hanford, J.J. Enghild, Z. Valnickova, and et al. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE) J Biol Chem 279 2004 50019
25. B.I. Hudson, A.M. Carter, E. Harja, and et al. Identification, classification, and expression of RAGE gene splice variants FASEB J 22 2008 1572
26. A. Raucci, S. Cugusi, A. Antonelli, and et al. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10) FASEB J 22 2008 3716
27. L. Zhang, M. Bukulin, E. Kojro, and et al. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases J Biol Chem 283 2008 35507
28. C. Cheng, K. Tsuneyama, R. Kominami, and et al. Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs Mod Pathol 18 2005 1385
29. M. Jabaudon, E. Futier, L. Roszyk, and et al. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients Crit Care Med 39 2011 480
30. R.M. Narvaez-Rivera, A. Rendon, M.C. Salinas-Carmona, and A.G. Rosas-Taraco Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis BMC Infect Dis 12 2012 15
31. L.B. Ware, T. Koyama, Z. Zhao, and et al. Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome Crit Care 17 2013 R253
32. F. Uhle, D. Nouland, S. Little, and et al. Plasmatic isoforms of cytokeratin 18 and RAGE after severe trauma: a longitudinal cohort study J Trauma Acute Care Surg 77 2014 577
33. F. Santilli, N. Vazzana, L.G. Bucciarelli, and G. Davi Soluble forms of RAGE in human diseases: clinical and therapeutical implications Curr Med Chem 16 2009 940
34. S. Zeng, N. Feirt, M. Goldstein, and et al. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice Hepatology 39 2004 422
35. G. Basta Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications Atherosclerosis 196 2008 9
36. P.M. Humpert, S. Kopf, Z. Djuric, and et al. Plasma sRAGE is independently associated with urinary albumin excretion in type 2 diabetes Diabetes Care 29 2006 1111
37. M. Andrassy, J. Igwe, F. Autschbach, and et al. Posttranslationally modified proteins as mediators of sustained intestinal inflammation Am J Pathol 169 2006 1223
38. K. Nakamura, S. Yamagishi, H. Adachi, and et al. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes Microvasc Res 76 2008 52
39. T. Kislinger, C. Fu, B. Huber, and et al. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression J Biol Chem 274 1999 31740
40. M.R. Chapman, L.S. Robinson, J.S. Pinkner, and et al. Role of Escherichia coli curli operons in directing amyloid fiber formation Science 295 2002 851
41. N. Sasaki, M. Takeuchi, H. Chowei, and et al. Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques Neurosci Lett 326 2002 117
42. M.A. Hofmann, S. Drury, C. Fu, and et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889
43. S.D. Yan, H. Zhu, A. Zhu, and et al. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis Nat Med 6 2000 643
44. T. Chavakis, A. Bierhaus, N. Al-Fakhri, and et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment J Exp Med 198 2003 1507
45. M. Busch, S. Franke, C. Ruster, and G. Wolf Advanced glycation end-products and the kidney Eur J Clin Invest 40 2010 742
46. R.D. Semba, J.C. Fink, K. Sun, B.G. Windham, and L. Ferrucci Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging J Ren Nutr 20 2010 74
47. T. Miyata, M.X. Fu, K. Kurokawa, C. van Ypersele de Strihou, S.R. Thorpe, and J.W. Baynes Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? Kidney Int 54 1998 1290
48. T. Miyata, Y. Ueda, T. Shinzato, and et al. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine J Am Soc Nephrol 7 1996 1198
49. H. Vlassara, L.J. Striker, S. Teichberg, H. Fuh, Y.M. Li, and M. Steffes Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats Proc Natl Acad Sci U S A 91 1994 11704
50. M.E. Andrades, R. Lorenzi, M. Berger, J.A. Guimaraes, J.C. Moreira, and F. Dal-Pizzol Glycolaldehyde induces fibrinogen post-translational modification, delay in clotting and resistance to enzymatic digestion Chem Biol Interact 180 2009 478
51. T.M. Buetler, E. Leclerc, A. Baumeyer, and et al. N(epsilon)-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response Mol Nutr Food Res 52 2008 370
52. A. Koch, R. Weiskirchen, E. Sanson, and et al. Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation Crit Care 14 2010 R179
53. L. Langouche, S. Vander Perre, J. Frystyk, A. Flyvbjerg, T.K. Hansen, and G. Van den Berghe Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin Crit Care 13 2009 R112
54. K. Sebekova, V. Kupcova, R. Schinzel, and A. Heidland Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation J Hepatol 36 2002 66
55. E. Yagmur, F. Tacke, C. Weiss, and et al. Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis Clin Biochem 39 2006 39
56. G. Basta, T. Navarra, P. De Simone, S. Del Turco, A. Gastaldelli, and F. Filipponi What is the role of the receptor for advanced glycation end products-ligand axis in liver injury? Liver Transpl 17 2011 633
57. J.M. Bohlender, S. Franke, G. Stein, and G. Wolf Advanced glycation end products and the kidney Am J Physiol Renal Physiol 289 2005 F645